The response of the hepatocyte to ischemia

Liver International

Volumn 27, Issue 1, 2007, Pages 6-16

  Massip salcedo, M ^a   Rosello Catafau J ^a,d   Prieto, J ^b   Avila M A ^b   Peralta, C ^c  

^a INST D INVESTIGACIONS B   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d Experimental Hepatic Ischemia Reperfusion Unit   (Spain)

Author keywords

Age; Cell death; Hepatocyte; Ischemia; Ischemic preconditioning; Reperfusion; Starvation; Steatosis

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CASPASE INHIBITOR; HEME OXYGENASE 1 ACTIVATOR; NITRIC OXIDE DONOR; PROTOPORPHYRIN; TOCOPHEROL; UNCLASSIFIED DRUG;

AGING; APOPTOSIS; CELL FUNCTION; CRYOPRESERVATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FATTY LIVER; HUMAN; ISCHEMIC PRECONDITIONING; LIVER BLOOD FLOW; LIVER CELL DAMAGE; LIVER FAILURE; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER ISCHEMIA; LIVER PROTECTION; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER TUMOR; LOW DRUG DOSE; NONHUMAN; NUTRITIONAL STATUS; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW; RISK REDUCTION; STARVATION; SURGICAL RISK;

ANIMALS; HEPATOCYTES; ISCHEMIA; TIME FACTORS;

EID: 33846441701     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01390.x     Document Type: Review

References (116)

1. Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003; 18: 891-902.
2. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003; 284: G15-26. Review.
3. Jaeschke H. Mechanisms of reperfusion injury after warm ischemia of the liver. J Hepatobiliary Pancreat Surg 1998; 5: 402-8. Review.
4. Toledo-Pereyra LH, Simmons RL, Najarian JS. Protection of the ischemic liver by donor pretreatment before transplantation. Am J Surg 1975; 129: 513-7.
5. Rosser BG, Gores GJ. Liver cell necrosis: Cellular mechanisms and clinical implications. Gastroenterology 1995; 108: 252-75. Review.
6. Bronk SF, Gores GJ. Efflux of protons from acidic vesicles contributes to cytosolic acidification of hepatocytes during ATP depletion. Hepatology 1991; 14: 626-33.
7. 2+i, and cytotoxicity in rat hepatocytes. J Biol Chem 1992; 267: 6654-63.
8. Carini R, Autelli R, Bellomo G, Albano E. Alterations of cell volume regulation in the development of hepatocyte necrosis. Exp Cell Res 1999; 248: 280-93.
9. Peralta C, Bulbena O, Bargallo R, Prats N, Gelpi E, Rosello-Catafau J. Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion. Transplantation 2000; 70: 1761-70.
10. Peralta C, Closa D, Hotter G, Gelpi E, Prats N, Rosello-Catafau J. Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun 1996; 229: 264-70.
11. Lentsch AB, Kato A, Yoshidome H, Mcmasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/ reperfusion injury. Hepatology 2000; 32: 169-73.
12. Bilzer M, Gerbes AL. Preservation injury of the liver: Mechanisms and novel therapeutic strategies. J Hepatol 2000; 32: 508-15. Review.
13. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917-36. Review.
14. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JF. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997; 100: 279-89.
15. Casillas-Ramirez A, Mosbah IB, Ramalho F, Rosello-Catafau J, Peralta C. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 2006; 79: 1881-1894.
16. Mckeown CM, Edwards V, Phillips MJ, Harvey PR, Petrunka CN, Strasberg SM. Sinusoidal lining cell damage: The critical injury in cold preservation ofliver allografts in the rat. Transplantation 1988; 46: 178-91.
17. Ikeda T, Yanaga K, Kishikawa K, Kakizoe S, Shimada M, Sugimachi K. Ischemic injury in liver transplantation: Difference in injury sites between warm and cold ischemia in rats. Hepatology 1992; 16: 454-61.
18. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology 1989; 10: 292-9.
19. Marzi I, Zhong Z, Lemasters JJ, Thurman RG. Evidence that graft survival is not related to parenchymal cell viability inrat liver transplantation. The importance of nonparenchymal cells. Transplantation 1989; 48: 463-8.
20. Huet PM, Nagaoka MR, Desbiens G, et al. Sinusoidal endothelial cell and hepatocyte death following cold ischemia-warm reperfusion of the rat liver. Hepatology 2004; 39: 1110-9.
21. Banga NR, Homer-Vanniasinkam S, Graham A, Al-Mukhtar A, White SA, Prasad KR. Ischaemic preconditioning in transplantation and major resection of the liver. Br J Surg 2005; 92: 528-38. Review.
22. Kukan M, Haddad PS. Role of hepatocytes and bile duct cells in preservation-reperfusion injury of liver grafts. Liver Transpl 2001; 7: 381-00.
23. Vajdova K, Graf R, Clavien PA. ATP-supplies in the cold-preserved liver: a long-neglected factor of organ viability. Hepatology 2002; 36: 1543-52. Review.
24. Sasaki H, Matsuno T, Tanaka N, Orita K. Activation of apoptosis during the reperfusion phase after rat liver ischemia. Transplant Proc 1996; 28: 1908-9.
25. Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 1998; 27: 1652-60.
26. Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999; 67: 1099-1105.
27. Gerwig T, Meissner H, Bilzer M, et al. Atrial natriuretic peptide preconditioning protects against hepatic preservation injury by attenuating necrotic and apoptotic cell death. J Hepatol 2003; 39: 341-8.
28. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note. Hepatology 1995; 21: 1465-8.
29. Natori S, Selzner M, Valentino KL, et al. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation 1999; 68: 89-96.
30. Rentsch M, Beham A, Iesalnieks I, Mirwald T, Anthuber M, Jauch KW. Impact of prolonged cold ischemia and reperfusion on apoptosis, activation of caspase 3, and expression of bax after liver transplantation in the rat. Transplant Proc 2001; 33: 850-1.
31. Natori S, Higuchi H, Contreras P, Gores GJ. The caspase inhibitor IDN-6556 prevents caspase activation and apoptosis in sinusoidal endothelial cells during liver preservation injury. Liver Transpl 2003; 9: 278-84.
32. Cursio R, Gugenheim J, Ricci JE, et al. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J 1999; 13: 253-61.
33. Jaeschke H. Reperfusion injury after warm ischemia or cold storage of the liver: Role of apoptotic cell death. Transplant Proc 2002; 34: 2656-8.
34. Rüdiger HA, Graf R, Clavien PA. Liver ischemia: Apoptosis as a central mechanism of injury. J Invest Surg 2003; 16: 149-59. Review.
35. Lemasters JJ. V. Necrapoptosis and the mitochondrial permeability transition: Shared pathways to necrosis and apoptosis. Am J Physiol 1999; 276: G1-6. Review.
36. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003; 125: 1246-57. Review.
37. Gonzalez-Flecha B, Cutrin JC, Boveris A. Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. J Clin Invest 1993; 91: 456-64.
38. Chien KR, Abrams J, Pfau RG, Farber JL. Prevention by chlorpromazine of ischemic liver cell death. Am J Pathol 1977; 88: 539-58.
39. Fernandez L, Heredia N, Grande L, et al. Preconditioning protects liver and lung damage in rat liver transplantation: Role of xanthine/xanthine oxidase. Hepatology 2002; 36: 562-72.
40. Klar E, Angelescu M, Zapletal C, Kraus T, Bredt M, Herfarth C. Definition of maximum cold ischemia time without reduction of graft quality in clinical liver transplantation. Transplant Proc 1998; 30: 3683-5.
41. Fernandez L, Heredia N, Peralta C, et al. Role of ischemic preconditioning and the portosystemic shunt in the prevention of liver and lung damage after rat liver transplantation. Transplantation 2003; 76: 282-9.
42. Hirasawa H, Chaundry IH, Baue AE. Improved hepatic function and survival with adenosine triphosphate-magnesium chloride after hepatic ischemia. Surgery 1978; 83: 655-62.
43. 2 on impaired transmembrane potential and protein synthesis in liver ischemia. Acta Chir Scand 1982; 148: 601-7.
44. 2 treatment. Am J Physiol 1985; 248: H804-11.
45. 2 treatment. J Surg Res 1986; 40: 167-75.
46. Anderson MD, Garrison RN, Ratcliffe DJ, Fry DE. Hepatic "no reflow" following transient ischemia. Circ Shock 1984; 13: 103.
47. 2 following hepatic ischemia. Am J Physiol 1983; 244: R695-702.
48. 2 administration. Circ Shock 1982; 9: 297-305.
49. 2. Adv Shock Res 1982; 8: 177-86.
50. Shah V, Kamath PS. Nitric oxide in liver transplantation: Pathobiology and clinical implications. Liver Transpl 2003; 9: 1-11. Review.
51. Stadler M, Nuyens V, Seidel L, Albert A, Boogaerts JG. Effect of nutritional status on oxidative stress in an ex vivo perfused rat liver. Anesthesiology 2005; 103: 978-86.
52. Pruim J, Van Woerden WF, Knol E, et al. Donor data in liver grafts with primary non-function - a preliminary analysis by the European Liver Registry. Transplant Proc 1989; 21: 2383-4.
53. Grazi GL, Cescon M, Ravaioli M, et al. A revised consideration on the use of very aged donors for liver transplantation. Am J Transplant 2001; 1: 61-8.
54. Fernandez L, Carrasco-Chaumel E, Serafin A, et al. Is ischemic preconditioning a useful strategy in steatotic liver transplantation? Am J Transplant 2004; 4: 888-99.
55. Zamboni F, Franchello A, David E, et al. Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transplant 2001; 15: 53-7.
56. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651-63. Review.
57. Busquets J, Xiol X, Figueras J, et al. The impact of donor age on liver transplantation: Influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation 2001; 71: 1765-71.
58. Karatzas T, Olson L, Ciancio G, et al. Expanded liver donor age over 60 years for hepatic transplantation. Transplant Proc 1997; 29: 2830-1.
59. Adam R, Astarcioglu I, Azoulay D, et al. Liver transplantation from elderly donors. Transplant Proc 1993; 25: 1556-7.
60. Adam R, Sanchez C, Astarcioglu I, Bismuth H. Deleterious effect of extended cold ischemia time on the posttransplant outcome of aged livers. Transplant Proc 1995; 27: 1181-3.
61. Todo S, Demetris AJ, Makowka L, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989; 47: 903-5.
62. Adam R, Reynes M, Johann M, et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc 1991; 23: 1538-40.
63. Jaeschke H. Preservation injury: Mechanisms, prevention and consequences. J Hepatol 1996; 25: 774-80. Review.
64. Cywes R, Greig PD, Sanabria JR, et al. Effect of intraportal glucose infusion on hepatic glycogen content and degradation, and outcome of liver transplantation. Ann Surg 1992; 216: 235-46.
65. Morgan GR, Sanabria JR, Clavien PA, et al. Correlation of donor nutritional status with sinusoidal lining cell viability and liver function in the rat. Transplantation 1991; 51: 1176-83.
66. Domenicali M, Vendemiale G, Serviddio G, et al. Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. Dig Liver Dis 2005; 37: 689-97.
67. Caraceni P, Nardo B, Domenicali M, et al. Ischemia-reperfusion injury in rat fatty liver: Role of nutritional status. Hepatology 1999; 29: 1139-46.
68. Skulachev VP. Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett 1998; 423: 275-80. Review.
69. Lenaz G, Cavazzoni M, Genova ML, et al. Oxidative stress, antioxidant defences and aging. Biofactors 1998; 8: 195-04. Review.
70. Guerrieri F, Vendemiale G, Grattagliano I, Cocco T, Pellecchia G, Altomare E. Mitochondrial oxidative alterations following partial hepatectomy. Free Radic Biol Med 1999; 26: 34-41.
71. Starke DW, Chen Y, Bapna CP, Lesnefsky EJ, Mieyal JJ. Sensitivity of protein sulfhydryl repair enzymes to oxidative stress. Free Radic Biol Med 1997; 23: 373-84.
72. Sankary HN, Chong A, Foster P, et al. Inactivation of Kupffer cells after prolonged donor fasting improves viability of transplanted hepatic allografts. Hepatology 1995; 22: 1236-42.
73. Uchida Y, Tamaki T, Tanaka M, et al. De novo protein synthesis induced by donor nutritional depletion ameliorates cold ischemia and reperfusion injury in rat liver. Transplant Proc 2000; 32: 1657-9.
74. Sumimoto R, Southard JH, Belzer FO. Livers from fasted rats acquire resistance to warm and cold ischemia injury. Transplantation 1993; 55: 728-32.
75. Gasbarrini A, Pasini P, Nardo B, et al. Chemiluminescent real time imaging of post-ischemic oxygen free radicals formation in livers isolated from young and old rats. Free Radic Biol Med 1998; 24: 211-6.
76. Gasbarrini A, Simoncini M, Di Campli C, et al. Ageing affects anoxia/ reoxygenation injury in rat hepatocytes. Scand J Gastroenterol 1998; 33: 1107-12.
77. Wang XH, Wang K, Zhang F, et al. Heme oxygenase-1 alleviates ischemia/ reperfusion injury in aged liver. World J Gastroenterol 2005; 11: 690-4.
78. Okaya T, Blanchard J, Schuster R, et al. Age-dependent responses to hepatic ischemia/reperfusion injury. Shock 2005; 24: 421-7.
79. Teramoto K, Bowers JL, Kruskal JB, Clouse ME. Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. Transplantation 1993; 56: 1076-82.
80. Hakamada K, Sasaki M, Takahashi K, Umehara Y, Konn M. Sinusoidal flow block after warm ischemia in rats with diet-induced fatty liver. J Surg Res 1997; 70: 12-20.
81. Ijaz S, Yang W, Winslet MC, Seifalian AM. Impairment of hepatic microcirculation in fatty liver. Microcirculation 2003; 10: 447-556. Review.
82. Selzner M, Rudiger HA, Sindram D, Madden J, Clavien PA. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 2000; 32(6): 1280-8.
83. Taneja C, Prescott L, Koneru B. Critical preservation injury in rat fatty liver is to hepatocytes, not sinusoidal lining cells. Transplantation 1998; 65: 167-72.
84. Koneru B, Fisher A, He Y, et al. Ischemic preconditioning in deceased donor liver transplantation: A prospective randomized clinical trial of safety and efficacy. Liver Transplant 2005; 11: 196-02.
85. Soltys K, Dikdan G, Koneru B. Oxidative stress in fatty livers of obese Zucker rats: Rapid amelioration and improved tolerance to warm ischemia with tocopherol. Hepatology 2001; 34: 13-8.
86. Nardo B, Caraceni P, Pasini P, et al. Increased generation of reactive oxygen species in isolated rat fatty liver during postischemic reoxygenation. Transplantation 2001; 71: 1816-20.
87. Caraceni P, Domenicali M, Vendemiale G, et al. The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury. J Surg Res 2005; 124: 160-8.
88. Serafin A, Rosello-Catafau J, Prats N, Xaus C, Gelpi E, Peralta C. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002; 161: 587-01.
89. Nakano H, Nagasaki H, Barama A, et al. The effects of N - acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet. Hepatology 1997; 26: 670-8.
90. Gao W, Connor HD, Lemasters JJ, Mason RP, Thurman RG. Primary nonfunction of fatty livers produced by alcohol is associated with a new, antioxidant-insensitive free radical species. Transplantation 1995; 59: 674-9.
91. Carrasco-Chaumel E, Rosello-Catafau J, Bartrons R, et al. Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation. J Hepatol 2005; 43: 997-1000.
92. Massip-Salcedo M, Casillas-Ramirez A, Franco-Gou R, et al. Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: Some answers. Am J Pathol 2006; 168: 1474-85.
93. Yamada S, Iida T, Tabata T, et al. Alcoholic fatty liver differentially induces a neutrophil-chemokine and hepatic necrosis after ischemia-reperfusion in rat. Hepatology 2000; 32: 278-88.
94. Yonezawa K, Tolba RH, Wetter A, Yamamoto Y, Yamaoka Y, Minor T. l -carnitine could not improve hepatic warm ischemia-reperfusion injury despite ameliorated blood flow. J Surg Res 2005; 125: 16-22.
95. Tolba RH, Putz U, Decker D, Dombrowski F, Lauschke H. l -carnitine ameliorates abnormal vulnerability of steatotic rat livers to cold ischemic preservation. Transplantation 2003; 76: 1681-6.
96. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
97. Serafin A, Fernandez-Zabalegui L, Prats N, Wu ZY, Rosello-Catafau J, Peralta C. Ischemic preconditioning: Tolerance to hepatic ischemia-reperfusion injury. Histol Histopathol 2004; 19: 281-9. Review.
98. Cutrin JC, Perrelli MG, Cavalieri B, Peralta C, Rosell Catafau J, Poli G. Microvascular dysfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radic Biol Med 2002; 33: 1200-8. Review.
99. Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 2003; 125: 1480-91. Review.
100. Carini R, De Cesaris MG, Splendore R, et al. Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes. Hepatology 2001; 33: 131-9.
101. Peralta C, Bartrons R, Serafin A, et al. Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology 2001; 34: 1164-73.
102. Peralta C, Bartrons R, Riera L, et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol 2000; 279: G163-71.
103. Franco-Gou R, Rosello-Catafau J, Casillas-Ramirez A, et al. How ischaemic preconditioning protects small liver grafts. J Pathol 2006; 208: 62-73.
104. Chouker A, Martignoni A, Schauer RJ, et al. Ischemic preconditioning attenuates portal venous plasma concentrations of purines following warm liver ischemia in man. Eur Surg Res 2005; 37: 144-52.
105. Ono K, Han J. The p38 signal transduction pathway: Activation and function. Cell Signal 2000; 12: 1-13. Review.
106. Kume M, Yamamoto Y, Saad S, et al. Ischemic preconditioning of the liver in rats: Implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 1996; 128: 251-8.
107. Yamagami K, Yamamoto Y, Toyokuni S, Hata K, Yamaoka Y. Heat shock preconditioning reduces the formation of 8-hydroxy-2′-deoxyguanosine and 4-hydroxy-2-nonenal modified proteins in ischemia-reperfused liver of rats. Free Radic Res 2002; 36: 169-76.
108. Serafin A, Rosello-Catafau J, Prats N, Gelpi E, Rodes J, Peralta C. Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 2004; 39: 688-98.
109. Schauer RJ, Gerbes AL, Vonier D, Op Den Winkel M, Fraunberger P, Bilzer M. Induction of cellular resistance against Kupffer cell-derived oxidant stress: A novel concept of hepatoprotection by ischemic preconditioning. Hepatology 2003; 37: 286-95.
110. Peralta C, Prats N, Xaus C, Gelpi E, Rosello-Catafau J. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology 1999; 30: 1481-9.
111. Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000; 232: 155-62.
112. Clavien PA, Selzner M, Rudiger HA, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843-50.
113. Nuzzo G, Giuliante F, Vellone M, et al. Pedicle clamping with ischemic preconditioning in liver resection. Liver Transpl 2004; 10: S53-7.
114. Azoulay D, Del Gaudio M, Andreani P, et al. Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: The ying and the yang. Ann Surg 2005; 242: 133-9.
115. Jassem W, Fuggle SV, Cerundolo L, Heaton ND, Rela M. Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation 2006; 81: 169-74.
116. Barrier A, Olaya N, Chiappini F, et al. Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J 2005; 19: 1617-26.